AGM Statement

The MedicX Fund Limited
11 February 2008



For Immediate Release                                         11 February 2008

                              MedicX Fund Limited
                  ('MedicX Fund', 'the Fund' or 'the Company')
                                 AGM Statement


MedicX Fund Limited (LSE: MXF), the specialist investor in modern purpose built
primary healthcare properties in the United Kingdom, announces that at the
annual general meeting to be held later today the Chairman will make the
following statement.

This statement also forms the Company's Interim Management Statement relating to
the period from 1 October 2007 to today's date.

'I am pleased to report that the MedicX Fund has performed in line with
expectations for the period since 1 October 2007.

The Company has completed the development of three properties at Evesham,
Wollaton and Rothwell during this period.

The Company has also entered into forward funding agreements to acquire three
more primary care medical centres at Lytham, Gosberton and Castlecroft. The
total acquisition cost of the properties is £18.2 million.

To date the Company has investments and commitments amounting to £161 million
across 45 properties. It continues to have a strong pipeline of investment
opportunities and is on track to invest £200 million by mid-2008. The portfolio
of properties is performing in line with our long-term objectives and there are
no material operational or financial issues to report.

The recent reduction in values in the commercial property sector has impacted
the primary care property sector. However, due to the quality of the income from
the asset class we believe that the impact has been relatively limited and does
not, in our opinion, impact the long term attractiveness of the sector. One of
the benefits of the adjustment in values is that it has enabled the group to
make acquisitions at attractive levels. We are optimistic about the prospects
for the MedicX Fund.

On 11 January 2008 a dividend of 2.5p per ordinary share was paid to
shareholders, making a total of 5p per share for the year. We intend to maintain
our progressive dividend policy.'



Jorge Tavares
Chairman





Information on MedicX Fund Limited

MedicX Fund Limited ('MXF' or the 'Company', or together with its subsidiaries,
the 'Group') the specialist investor in modern purpose-built primary healthcare
properties in the United Kingdom, listed on the London Stock Exchange in
November 2006. It has committed investment of £161 million and a portfolio of 45
properties.

The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised
and regulated by the Financial Services Authority, and is a subsidiary of the
MedicX Group. The MedicX Group is a specialist investor, developer and manager
of primary healthcare properties with a team of 31 operating across 4 regional
offices.


                                     -Ends-


For further information please contact:

MedicX Fund [phone]
Jorge Tavares, Chairman

MedicX Group [phone]
Keith Maddin, Chairman
Mike Adams, Managing Director

Buchanan Communications [phone]
Charles Ryland, Partner
Mary-Jane Johnson, Partner






                      This information is provided by RNS
            The company news service from the London Stock Exchange